Oxytocin

Uterotonic (oxytocin receptor agonist)

For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.

Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026

Oxytocin (Uterotonic (oxytocin receptor agonist)) – indications: Prophylaxis of postpartum haemorrhage (after delivery of the baby), Postpartum haemorrhage due to uterine atony – treatment (1st choice). Weight-based dosing in mg and ml in the app, with sources.

Indications

Prophylaxis of postpartum haemorrhage (after delivery of the baby)
Postpartum haemorrhage due to uterine atony – treatment (1st choice)

Complete in the app

Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.

Open in the app Pocket book

Used in

Obstetric emergencies

Sources and guidelines

DGGG/OEGGG/SGGG. Peripartale Blutungen, Diagnostik und Therapie. S2k-Leitlinie, AWMF-Registernummer 015-063, August 2022 (gültig bis 07/2027). Englische Fassung: Geburtshilfe Frauenheilkd, doi 10.1055/a-2073-9615.
World Health Organization, International Federation of Gynecology and Obstetrics (FIGO), International Confederation of Midwives (ICM). Consolidated guidelines on the prevention, diagnosis and treatment of postpartum haemorrhage. Genf, 05.10.2025.